1- Weight Loss Results: In a Phase II trial [3], retatrutide achieved up to 24.2% average body weight reduction after 48 weeks of treatment in adults with obesity but without diabetes
Oral or sublingual BPC-157 is preferred for gut health because the peptide acts directly on the GI mucosa when delivered through the digestive tract
BPC-157 has been shown to enhance healing of the gastrointestinal tract in nearly all models of damage, including NSAID toxicity, alcohol-induced ulcers, colitis, and anastomotic leakage. Sikiric, P
For patients with significant fatigue or cognitive complaints, IV NAD typically produces faster and more pronounced results
However, growth hormone continues to play an important role throughout adult life
Studies document NO production effects on endothelial proliferation and vessel dilation